Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
MedSIR
Rigshospitalet, Denmark
Hoffmann-La Roche
University of California, San Francisco
Emory University
National Cancer Institute (NCI)
National Center for Complementary and Integrative Health (NCCIH)